ROS levels were detected using 2,7-dichlorofluorescein diacetate according to the manufacturer's protocol
Your care team will let you know when tests will be performed to measure carnitine levels in the blood
Extra caution is advised in people with: A history of pancreatitis Severe acidity or gastroparesis (very slow stomach emptying) Known gallstones or gallbladder disease Advanced kidney disease Significant diabetic eye disease (retinopathy) A very low BMI or a history of eating disorders Pregnancy, plans to become pregnant, or breastfeeding, since some GLP-1 medicines stay in the body for several weeks after stopping Significant depression, who should be monitored carefully Upcoming surgery, endoscopy, or a procedure needing anaesthesia or sedation, since delayed stomach emptying can raise aspiration risk and temporary stopping may be advised How GLP-1 side effects usually progress: a typical timeline Every person is different, but clinical practice and studies suggest a rough pattern [6]: First 2 to 6 weeks: nausea, early fullness, and constipation are most common

In the dorsal root ganglion (DRG), hyperglycemia leads to reduced synthesis of neurofilament, GAP43 and -tubulin, alongside an increased expression of stress-related proteins (HSP and PARP)
Elevated BCAA suppresses the development and metastasis of breast cancer
This could improve muscle growth, fat loss, and recovery while keeping side effects lower